David Henry Mack - 03 Jun 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: President and CEO, Director
Signature: /s/ David H. Mack
Issuer symbol: PMVP
Transactions as of: 03 Jun 2021
Net transactions value: +$5,300
Form type: 4
Filing time: 04 Jun 2021, 19:13:27 UTC
Previous filing: 24 May 2021
Next filing: 29 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMVP	Common Stock	Options Exercise	$5,300	+10,000	+405%	$0.5300^*	12,470	20 May 2021	Direct
holding	PMVP	Common Stock						227,915	03 Jun 2021	See footnote	F1
holding	PMVP	Common Stock						56,978	03 Jun 2021	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMVP	Stock Option (right to buy)	Options Exercise	$0	-10,000	-2.1%	$0.000000	475,074	21 May 2021	Common Stock	10,000	$0.5300	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
F2	The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
F3	The shares subject to the option are fully vested and immediately exercisable.